Hanover - Delayed Quote EUR
Valneva SE (AYJ.HA)
2.7240
-0.0340
(-1.23%)
At close: June 6 at 5:25:32 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-46,934
-67,218
-202,744
-245,343
76,901
Investing Cash Flow
-10,758
76,916
-20,585
-29,054
-93,117
Financing Cash Flow
32,557
30,682
63,081
215,116
154,504
End Cash Position
151,505
168,271
126,080
286,532
346,642
Capital Expenditure
-13,385
-16,444
-14,312
-29,322
-93,171
Issuance of Capital Stock
--
--
0
189,837
166,823
Issuance of Debt
--
--
81,111
39,331
859
Repayment of Debt
-5,551
-6,487
-5,224
-4,841
-4,761
Repurchase of Capital Stock
--
--
-240
--
--
Free Cash Flow
-60,319
-83,662
-217,056
-274,665
-16,270
12/31/2021 - 12/9/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NXOA.BE Nicox SA
0.2260
-0.88%
IMR.BE AC Immune SA
1.7820
+18.80%
5CV.HA CureVac NV
3.8120
-0.78%
BT1.BE Bone Therapeutics SA
0.0018
0.00%
2LB.MU Iovance Biotherapeutics Inc
1.5644
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.3285
-5.06%
ABRT.CN Albert Labs International Corp.
0.0050
0.00%
2LB.F Iovance Biotherapeutics, Inc.
1.5496
-4.11%
ALINT.PA IntegraGen SA
0.5220
0.00%
W1H.MU Onco-Innovations Ltd
0.9600
-0.26%